Evogene Ltd.

Listed Company
EVGNCIK 0001574565NasdaqNon-AcceleratedAgricultural ChemicalsL3ILFY ends Dec 31
Period
FY 2025
Revenue
Net Income
$-7.83M
Total Assets
$20.05M
Equity
Shares Out
8.72M
Op. Cash Flow

Business

Evogene Ltd. is a computational biology company that applies advanced AI and big-data analytics to accelerate discovery and development of life-science products. It offers computational platforms and tech-engines (MicroBoost AI, ChemPass AI, GeneRator AI) plus experimental validation and screening capabilities to identify and optimize microbial, small-molecule and genetic candidates. Operations are organized through business segments and subsidiaries including Biomica (human health), Lavie Bio and AgPlenus (agriculture), and Casterra and Finally (industrial and food applications). Evogene deploys its technologies via licensing, collaborations and subsidiary-led development across global agricultural, pharmaceutical and industrial channels.

Summary from filing dated 2025-03-27

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue
Net income$-7.83M
Total assets$20.05M
Total liabilities$8.07M
Stockholders' equity
Operating cash flow

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro